Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Anti-HCMV pseudopeptides disclosed by Bayer

Oct. 30, 1997

Diester prodrugs of antiviral acyclic nucleoside disclosed by Medivir

Oct. 29, 1997

Lamisil's safety profile confirmed

Oct. 28, 1997

Sankyo isolates antibacterial agent F-12436

Oct. 23, 1997

PathoGenesis initiates phase II trial with new antiinfective for tuberculosis

Oct. 22, 1997

New nonimmunosuppressive CsA derivative with potent anti-Toxoplasma activity

Oct. 22, 1997

Taisho, Abbott to collaborate on macrolide antibacterials

Oct. 21, 1997

NIH researcher outlines ups and downs of malaria vaccine research

Oct. 21, 1997

Anti-Infective Drugs Advisory Committee to discuss three NDAs

Oct. 20, 1997

Viragen considers genital herpes as possible target for Omniferon

Oct. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...